Novavax Inc vs Weibo Corp — how do they compare? Novavax Inc trades at $7.95 (market cap $1.31B), while Weibo Corp trades at $7.77 (market cap $1.93B). The key difference: Weibo Corp is the larger of the two by market cap, and Weibo Corp pays a 7.75% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | WB | |
|---|---|---|
Market Cap | $1.31B | $1.93B |
Sector | Health | Media |
52-Week High | $11.19 | $12.83 |
52-Week Low | $6.22 | $7.20 |
Enterprise Value | $889.30M | $1.20B |
Dividend Yield | — | 7.75% |
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $7.89, down 0.75% on the day, with a bullish technical signal despite mixed indicators. The company reported a strong Q2 2026 earnings beat, raising its full-year revenue outlook, while maintaining a low valuation with a P/E of 3.14 and EV/EBITDA of 1.72. However, negative net income margin and shareholder equity highlight financial challenges.
The outlook is cautiously optimistic, driven by partnership milestones with Sanofi and cost reductions, but risks include persistent cash burn and competitive vaccine market pressures. Analyst consensus leans bullish with 74% buy ratings, suggesting potential upside if execution improves.
No Aura AI signal available yet.
Trailing returns across standard periods
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →